Senior insider sale
CHIEF EXECUTIVE OFFICER at CUE BIOPHARMA, INC. — senior position signals high conviction
$1.90M
69.34K shares
What this filing means
LIN SHAO-LEE plans to sell 69.34K shares of CUE BIOPHARMA, INC. valued at approximately $1.90M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/14/2026ACC: 0001725092-26-000017
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2026
69.34K
Shares to sell
$1.90M
Approx. market value
11.09K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units vesting under registered plan
Compensation
10/9/2026
11.09KTotal acquired11.09K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/9/2026 | Restricted Stock Units vesting under registered plan Compensation | 11.09K | — |
| Total | 11.09K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
18.26K
Market value
$516.0K
8/13/2026
—Completed
Units to sell
40K
Market value
$1.08M
8/12/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
11.09K
Market value
$305.5K
10/12/2026
Total
Units
69.34K
Value
$1.90M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/13/2026 | 18.26K | $516.0K | — | Completed |
8/12/2026 | 40K | $1.08M | — | Completed |
| Planned — Approximate Date | ||||
10/12/2026 | 11.09K | $305.5K | NASDAQ | Planned |
| Total | 69.34K | $1.90M | ||